Factory source 2 6-Diaminopurine Riboside113 - (R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4 Linagliptin Alogliptin Trelagliptin Intermediate – Ruifu

Commercial Supply Alogliptin Benzoate (CAS: 850649-62-6) Related Intermediates:
6-Chloro-3-methyluracil CAS: 4318-56-3
2-Cyanobenzyl Bromide CAS: 22115-41-9
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS: 334618-23-4
2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile CAS: 865758-96-9

Commercial Supply Trelagliptin Succinate (CAS: 1029877-94-8) Related Intermediates:
6-Chloro-3-methyluracil CAS: 4318-56-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS: 334618-23-4
2-Cyano-5-Flurobenzyl Bromide CAS: 421552-12-7

Package: Bottle, Aluminum foil bag, 25kg/Cardboard drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture.

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-(-)-3-Aminopiperidine Dihydrochloride (CAS: 334618-23-4) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis, suach as Alogliptin Benzoate (CAS: 850649-62-6), Trelagliptin Succinate (CAS: 1029877-94-8), and Linagliptin (CAS 668270-12-0).

Alogliptin Benzoate (CAS: 850649-62-6)  is a type-2 diabetes medication, and it is a type of serine protease dipeptidyl peptidase IV (DPP-4) inhibitor. Alogliptin, used alone or in combination with other blood sugar-lowering medication, is usually well-tolerated in type-2 diabetes patients.

Trelagliptin Succinate (CAS: 1029877-94-8) (SYR-472) is a selective, long acting dipeptidyl peptidase-4 (DPP-4) inhibitor  used for the treatment of type 2 diabetes mellitus. An antidiabetic agent.Trelagliptin Succinate was approved for use in Japan in March 2015.